Global Mobile Cardiac Telemetry (MCT) Market is expected to grow at a substantial CAGR of 6.3% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below:
The global mobile cardiac telemetry (MCT) market is a fragmented market which includes key players and local players. The market is growing owing to the favourable market scenario. The market has a prominent growth in upcoming years due to growing number of cardiac diseases and increased diagnostic yield of the MCT devices.
The market has witnessed developments in terms of merger and acquisitions or product launches to enhance the product portfolio to meet the rising demand of mobile cardiac telemetry (MCT) market. For instance, In March 2019, Hill-Rom acquired Voalte, developer of smartphone solutions which supports simplifying caregiver communication. After the acquisition, the companies offer a single integrated solution for clients – providing mobile caregiver access to mobile information from intelligent hospital beds, health care call and patient surveillance technologies.
BioTelemetry, Inc. has dominated the mobile cardiac telemetry (MCT) market. The other key players in the market are Medicalgorithmics.com, The ScottCare Corporation, Medicomp Inc., nationalcardiac.com, ACSDiagnostics, Preventice Solutions, Inc., iRhythm Technologies, Inc., CorVitals, Inc., Asahi Kasei Corporation, Biotricity, Hill-Rom Services Inc., BIOTRONIK SE & Co. KG, Bittium, Cardiac Insight Inc. among others.
BioTelemetry, Inc. is headquartered in Pennsylvania, U.S., was founded in 1994. The company is leading in mobile and wireless medical technology industry. The product categories of the company include mobile cardiac telemetry, event monitoring, extended holter monitoring in which mobile cardiac telemetry is market focused category. The company has approx. 1500 employees.
The company has its global networks through direct sales representatives and distributors in the U.S., Europe and Asia-Pacific. The company has various subsidiaries such as Geneva Healthcare, Inc. (U.S.), Universal Medical Laboratory, Inc (Puerto Rico), Telcare (U.S.), CardioNet (U.S.), LifeWatch AG (Switzerland).
iRhythm Technologies, Inc.
iRhythm Technologies, Inc. is headquartered in California, U.S. was founded in 2008. The company focus on developing advanced systems for cardiology. The ownership of the company is public. The product categories of the company include Zio XT, Zio AT in which Zio AT is market focused category. The company has approx. 748 employees.
The company has its global networks through direct sales representatives and distributors in the Canada, Germany, Ireland, Israel, Italy, Scotland, Spain, U.S. and U.K.
Hill-Rom Services Inc.
Hill-Rom Services Inc. is headquartered in Illinois, U.S., was founded in 1969. The company is engaged in medical technology including advanced connected care. The ownership of the company is public. The company operates through three business segments which include patient support systems, front line care, surgical solutions in which patient support systems is market focused segment. The product categories of the company include patient monitoring, blood pressure measurement, thermometry, cardiopulmonary, medical lighting, animal, health, population, health management technologies in which patient monitoring is market focused category. The company has More than 10,000 employees.
The company has its global networks through direct sales representatives and distributors in the Asia/Australia, Europe, Latin America, Middle East/Africa, North America. The company has various subsidiaries such as Hillrom Pty Ltd (Australia), Trumpf Med Pty Limited (Australia), Hillrom Shanghai, Ltd. (China), Hillrom India Private, Ltd. (India) and other.